Constitutive expression of IL-2Rbeta chain and its effects on IL-2-induced vascular leak syndrome

Cytokine

Volumn 32, Issue 6, 2005, Pages 280-286

  Assier, Eric ^a   Jullien, Valérie ^a   Lefort, Jean ^a   Moreau, Jean Louis ^a   Vargaftig, B Boris ^a   Silva J R, Jose Lapa E ^b   Thèze, Jacques ^a  

^a INSTITUT PASTEUR   (France)

^b FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

Human IL 2Rbeta transgenic mice; IL 2; IL 2 receptors; Vascular leak syndrome (VLS)

Indexed keywords

INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 2 RECEPTOR BETA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRONCHOSPASM; CAPILLARY LEAK SYNDROME; CONTROLLED STUDY; HUMAN VERSUS ANIMAL COMPARISON; LUNG EDEMA; LUNG LAVAGE; LYMPHOCYTE; MALE; MOUSE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSGENIC MOUSE; WILD TYPE;

AIRWAY RESISTANCE; ANIMALS; BRONCHOALVEOLAR LAVAGE FLUID; CAPILLARY LEAK SYNDROME; CELL COUNT; CELL MOVEMENT; GENE EXPRESSION; HUMANS; INTERLEUKIN-2; INTERLEUKIN-2 RECEPTOR BETA SUBUNIT; LUNG; LYMPHOCYTES; MALE; METHACHOLINE CHLORIDE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; NEUTROPHILS; ORGAN SIZE; PEROXIDASE; PLETHYSMOGRAPHY, WHOLE BODY; PROTEINS; RECEPTORS, INTERLEUKIN-2;

ANIMALIA; MUS MUSCULUS;

EID: 31744432271     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cyto.2005.10.006     Document Type: Article

References (38)

1. K.A. Smith Interleukin-2: inception, impact, and implications Science 240 1988 1169 1176
2. H. Schorle, T. Holtschke, T. Hunig, A. Schimpl, and I. Horak Development and function of T cells in mice rendered interleukin-2 deficient by gene targeting Nature 352 1991 621 624
3. J. Thèze, P. Alzari, and J. Bertoglio IL-2 and IL-2 receptors: recent advances and new immunological functions Immunol Today 17 1996 481 486
4. X.C. Li, G. Demirci, S. Ferrari-Lacraz, C. Groves, A. Coyle, and T.R. Malek IL-15 and IL-2: a matter of life and death for T cells in vivo Nat Med 7 2001 114 118
5. M. Lotze, Y. Matory, A. Rayner, S. Ettinghausen, J. Vetto, and C. Seipp Clinical effects and toxicity of interleukin-2 in patients with cancer Cancer 58 1986 2764 2772
6. S.A. Rosenberg, M.T. Lotze, L.M. Muul, A.E. Chang, F.P. Avis, and S. Leitman A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high-dose interleukin-2 alone N Engl J Med 316 1987 889 897
7. E. Leef Jacobson, F. Pilaro, and K.A. Smith Rational interleukin 2 therapy for HIV positive individuals: daily low doses enhance immune function without toxicity Proc Natl Acad Sci U S A 93 1996 10405 10410
8. D. David, L. Nait-Ighil, B. Dupont, J. Maral, B. Gachot, and J. Theze Rapid effect of interleukin-2 therapy in human immunodeficiency virus-infected patients whose CD4 cell counts increase only slightly in response to combined antiretroviral treatment J Infect Dis 183 2001 730 735
9. K.A. Smith Low-dose daily interleukin-2 immunotherapy: accelerating immune restoration and expanding HIV-specific T-cell immunity without toxicity AIDS 15 Suppl 2 2001 S28 S35
10. +T cells Blood 100 2002 2159 2167
11. V. Natarajan, R.A. Lempicki, I. Sereti, Y. Badralmaa, J.W. Adelsberger, and J.A. Metcalf Increased peripheral expansion of naive CD4+ T cells in vivo after IL-2 treatment of patients with HIV infection Proc Natl Acad Sci U S A 99 2002 10712 10717
12. G.J. Locker, S. Kapiotis, M. Veitl, R.M. Mader, B. Stoiser, and J. Kofler Activation of endothelium by immunotherapy with interleukin-2 in patients with malignant disorders Br J Haematol 105 1999 912 919
13. A. Lentsch, F. Miller, and M. Edwards Mechanisms of leukocyte-mediated tissue injury induced by interleukin-2 Cancer Immunol Immunother 47 1999 243 248
14. E. Assier, V. Jullien, J. Lefort, J.L. Moreau, J.P. Di Santo, and B.B. Vargaftig NK cells and polymorphonuclear neutrophils are both critical for IL-2-induced pulmonary vascular leak syndrome J Immunol 172 2004 7661 7668
15. T. Uchiyama, S. Broder, and T.A. Waldmann A monoclonal antibody (anti-Tac) reactive with activated and functionally mature human T cells. I. Production of anti-Tac monoclonal antibody and distribution of Tac (+) cells J Immunol 126 1981 1393 1397
16. W.J. Leonard, J.M. Depper, G.R. Crabtree, S. Rudikoff, J. Pumphrey, and R.J. Robb Molecular cloning and expression of cDNAs for the human interleukin-2 receptor Nature 311 1984 626 631
17. K. Teshigawara, H.M. Wang, K. Kato, and K.A. Smith Interleukin 2 high-affinity receptor expression requires two distinct binding proteins J Exp Med 165 1987 223 238
18. M. Hatakeyama, M. Tsudo, S. Minamoto, T. Kono, T. Doi, and T. Miyata Interleukin-2 receptor beta chain gene: generation of three receptor forms by cloned human alpha and beta chain cDNA's Science 244 1989 551 556
19. M. Tsudo, F. Kitamura, and M. Miyasaka Characterization of the interleukin 2 receptor beta chain using three distinct monoclonal antibodies Proc Natl Acad Sci U S A 86 1989 1982 1986
20. T. Takeshita, H. Asao, K. Ohtani, N. Ishii, S. Kumaki, and N. Tanaka Cloning of the gamma chain of the human IL-2 receptor Science 257 1992 379 382
21. P.E. Kovanen, and W.J. Leonard Cytokines and immunodeficiency diseases: critical roles of the gamma(c)-dependent cytokines interleukins 2, 4, 7, 9, 15, and 21, and their signaling pathways Immunol Rev 202 2004 67 83
22. D. David, L. Bani, J.L. Moreau, C. Demaison, K. Sun, and O. Salvucci Further analysis of interleukin-2 receptor subunit expression on the different human peripheral blood mononuclear cell subsets Blood 91 1998 165 172
23. P. Chastagner, J.L. Moreau, Y. Jacques, T. Tanaka, M. Miyasaka, and M. Kondo Lack of intermediate affinity IL-2 receptor in mice leads to dependence on IL-2 receptor α, β and γ chain expression for T cell growth Eur J Immunol 26 1996 201 206
24. C. Demaison, P. Chastagner, J.L. Moreau, and J. Theze Ligand-induced autoregulation of IL-2 receptor alpha chain expression in murine T cell lines Int Immunol 8 1996 1521 1528
25. M. Asano, Y. Ishida, H. Sabe, M. Kondo, K. Sugamura, and T. Honjo IL-2 can support growth of CD8+ T cells but not CD4+ T cells of human IL-2 receptor beta-chain transgenic mice J Immunol 153 1994 5373 5381
26. F. Gesbert, J.L. Moreau, and J. Theze IL-2 responsiveness of CD4 and CD8 lymphocytes: further investigations with human IL-2Rbeta transgenic mice Int Immunol 17 2005 1093 1102
27. C. Pitton, A. Rebollo, J. Van Snick, J. Theze, and A. Garcia High-affinity and intermediate-affinity forms of the human interleukin 2 receptor, expressed in an interleukin 9-dependent murine T cell line, deliver proliferative signals via differences in their transduction pathways Cytokine 5 1993 362 371
28. R. Eckenberg, T. Rose, J.L. Moreau, R. Weil, F. Gesbert, and S. Dubois The first alpha helix of interleukin (IL)-2 folds as a homotetramer, acts as an agonist of the IL-2 receptor beta chain, and induces lymphokine-activated killer cells J Exp Med 191 2000 529 540
29. E. Hamelmann, J. Schwarze, K. Takeda, A. Oshiba, G.L. Larsen, and C.G. Irvin Noninvasive measurement of airway responsiveness in allergic mice using barometric plethysmography Am J Respir Crit Care Med 156 1997 766 775
30. J.S. Warren, K.R. Yabroff, D.G. Remick, S.L. Kunkel, S.W. Chensue, and R.G. Kunkel Tumor necrosis factor participates in the pathogenesis of acute immune complex alveolitis in the rat J Clin Invest 84 1989 1873 1882
31. S. Hirano Migratory responses of PMN after intraperitoneal and intratracheal administration of lipopolysaccharide Am J Physiol 270 1996 L836 L845
32. C. Demaison, L. Fiette, V. Blanchetiere, A. Schimpl, J. Theze, and P. Froussard IL-2 receptor alpha-chain expression is independently regulated in primary and secondary lymphoid organs J Immunol 161 1998 1977 1982
33. T.R. Malek The main function of IL-2 is to promote the development of T regulatory cells J Leukoc Biol 74 2003 961 965
34. S.C. Hornyak, D.M. Orentas, L.M. Karavodin, and K.R. Gehlsen Histamine improves survival and protects against interleukin-2-induced pulmonary vascular leak syndrome in mice Vascul Pharmacol 42 2005 187 193
35. A. Mustafa, R.J. McKallip, M. Fisher, R. Duncan, P.S. Nagarkatti, and M. Nagarkatti Regulation of interleukin-2-induced vascular leak syndrome by targeting CD44 using hyaluronic acid and anti-CD44 antibodies J Immunother 25 2002 476 488
36. R.J. McKallip, M. Fisher, Y. Do, A.K. Szakal, U. Gunthert, and P.S. Nagarkatti Targeted deletion of CD44v7 exon leads to decreased endothelial cell injury but not tumor cell killing mediated by interleukin-2-activated cytolytic lymphocytes J Biol Chem 278 2003 43818 43830
37. P. Hu, M. Mizokami, G. Ruoff, L.A. Khawli, and A.L. Epstein Generation of low-toxicity interleukin-2 fusion proteins devoid of vasopermeability activity Blood 101 2003 4853 4861
38. T. Rose, J.L. Moreau, R. Eckenberg, and J. Theze Structural analysis and modeling of a synthetic interleukin-2 mimetic and its interleukin-2Rbeta2 receptor J Biol Chem 278 2003 22868 22876